Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2007 | 1 |
2008 | 1 |
2012 | 1 |
2018 | 1 |
2020 | 1 |
2021 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial.
Nat Med. 2018 May;24(5):628-637. doi: 10.1038/s41591-018-0009-7. Epub 2018 Apr 30.
Nat Med. 2018.
PMID: 29713086
Free PMC article.
Clinical Trial.
Dissecting the heterogeneity of triple-negative breast cancer.
Metzger-Filho O, Tutt A, de Azambuja E, Saini KS, Viale G, Loi S, Bradbury I, Bliss JM, Azim HA Jr, Ellis P, Di Leo A, Baselga J, Sotiriou C, Piccart-Gebhart M.
Metzger-Filho O, et al.
J Clin Oncol. 2012 May 20;30(15):1879-87. doi: 10.1200/JCO.2011.38.2010. Epub 2012 Mar 26.
J Clin Oncol. 2012.
PMID: 22454417
Review.
Item in Clipboard
Integrated Multimodal Analyses of DNA Damage Response and Immune Markers as Predictors of Response in Metastatic Triple-Negative Breast Cancer in the TNT Trial (NCT00532727).
Tovey H, Sipos O, Parker JS, Hoadley KA, Quist J, Kernaghan S, Kilburn L, Salgado R, Loi S, Kennedy RD, Roxanis I, Gazinska P, Pinder SE, Bliss J, Perou CM, Haider S, Grigoriadis A, Tutt A, Cheang MCU.
Tovey H, et al.
Clin Cancer Res. 2023 Sep 15;29(18):3691-3705. doi: 10.1158/1078-0432.CCR-23-0370.
Clin Cancer Res. 2023.
PMID: 37574209
Free PMC article.
Item in Clipboard
'Triple negative' breast cancer: a new area for phase III breast cancer clinical trials.
Kilburn LS; TNT Trial Management Group.
Kilburn LS, et al.
Clin Oncol (R Coll Radiol). 2008 Feb;20(1):35-9. doi: 10.1016/j.clon.2007.09.010. Epub 2007 Oct 31.
Clin Oncol (R Coll Radiol). 2008.
PMID: 17977700
No abstract available.
Item in Clipboard
Assessment of structural chromosomal instability phenotypes as biomarkers of carboplatin response in triple negative breast cancer: the TNT trial.
Sipos O, Tovey H, Quist J, Haider S, Nowinski S, Gazinska P, Kernaghan S, Toms C, Maguire S, Orr N, Linn SC, Owen J, Gillett C, Pinder SE, Bliss JM, Tutt A, Cheang MCU, Grigoriadis A.
Sipos O, et al.
Ann Oncol. 2021 Jan;32(1):58-65. doi: 10.1016/j.annonc.2020.10.475. Epub 2020 Oct 21.
Ann Oncol. 2021.
PMID: 33098992
Free PMC article.
Item in Clipboard
Cite
Cite